Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Candesartan cilexetil (candesartan) is a drug used for treating high blood pressure (hypertension). It is in a class of drugs called angiotensin receptor blockers (ARBs) which includes losartan (Cozaar), valsartan (Diovan), and irbesartan (Avapro). Angiotensin, formed in the blood by the action of angiotensin converting enzyme (ACE), is a powerful chemical that attaches to angiotensin receptors found in many tissues but primarily on smooth muscle cells surrounding blood vessels. Angiotensin's attachment to the receptors causes the muscle cells to contract and the blood vessels to narrow (vasoconstrict) which leads to an increase in blood pressure. Candesartan blocks the angiotensin receptor and therby prevents the action of angiotensin. As a result blood vessels expand and blood pressure is reduced. Candesartan was approved by the FDA in 1998.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Candesartan Cilexetil Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Candesartan Cilexetil Drug market. Detailed analysis of key players, along with key growth strategies adopted by Candesartan Cilexetil Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
LUPIN
ANI Pharmaceuticals
Zydus Pharmaceuticals
Mylan
MACLEODS
Teva
Sun Pharmaceutical
Chongqing Shenghuaxi Pharma
AstraZeneca
Alembic Pharmaceuticals
By Type:
4 mg Tablets
8 mg Tablets
16 mg Tablets
32 mg Tablets
By End-User:
Essential hypertension in adults
Hypertension in children and adolescents aged 6 to < 18 years
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Candesartan Cilexetil Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Candesartan Cilexetil Drug Market Size and Growth Rate of 4 mg Tablets from 2016 to 2027
-
1.3.2 China Candesartan Cilexetil Drug Market Size and Growth Rate of 8 mg Tablets from 2016 to 2027
-
1.3.3 China Candesartan Cilexetil Drug Market Size and Growth Rate of 16 mg Tablets from 2016 to 2027
-
1.3.4 China Candesartan Cilexetil Drug Market Size and Growth Rate of 32 mg Tablets from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Candesartan Cilexetil Drug Market Size and Growth Rate of Essential hypertension in adults from 2016 to 2027
-
1.4.2 China Candesartan Cilexetil Drug Market Size and Growth Rate of Hypertension in children and adolescents aged 6 to < 18 years from 2016 to 2027
-
1.4.3 China Candesartan Cilexetil Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Candesartan Cilexetil Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Candesartan Cilexetil Drug by Major Types
-
3.4.1 Market Size and Growth Rate of 4 mg Tablets
-
3.4.2 Market Size and Growth Rate of 8 mg Tablets
-
3.4.3 Market Size and Growth Rate of 16 mg Tablets
-
3.4.4 Market Size and Growth Rate of 32 mg Tablets
4 Segmentation of Candesartan Cilexetil Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Candesartan Cilexetil Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Candesartan Cilexetil Drug in Essential hypertension in adults
-
4.4.2 Market Size and Growth Rate of Candesartan Cilexetil Drug in Hypertension in children and adolescents aged 6 to < 18 years
-
4.4.3 Market Size and Growth Rate of Candesartan Cilexetil Drug in Others
5 Market Analysis by Regions
-
5.1 China Candesartan Cilexetil Drug Production Analysis by Regions
-
5.2 China Candesartan Cilexetil Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Candesartan Cilexetil Drug Landscape Analysis
-
6.1 North China Candesartan Cilexetil Drug Landscape Analysis by Major Types
-
6.2 North China Candesartan Cilexetil Drug Landscape Analysis by Major End-Users
7 Central China Candesartan Cilexetil Drug Landscape Analysis
-
7.1 Central China Candesartan Cilexetil Drug Landscape Analysis by Major Types
-
7.2 Central China Candesartan Cilexetil Drug Landscape Analysis by Major End-Users
8 South China Candesartan Cilexetil Drug Landscape Analysis
-
8.1 South China Candesartan Cilexetil Drug Landscape Analysis by Major Types
-
8.2 South China Candesartan Cilexetil Drug Landscape Analysis by Major End-Users
9 East China Candesartan Cilexetil Drug Landscape Analysis
-
9.1 East China Candesartan Cilexetil Drug Landscape Analysis by Major Types
-
9.2 East China Candesartan Cilexetil Drug Landscape Analysis by Major End-Users
10 Northeast China Candesartan Cilexetil Drug Landscape Analysis
-
10.1 Northeast China Candesartan Cilexetil Drug Landscape Analysis by Major Types
-
10.2 Northeast China Candesartan Cilexetil Drug Landscape Analysis by Major End-Users
11 Southwest China Candesartan Cilexetil Drug Landscape Analysis
-
11.1 Southwest China Candesartan Cilexetil Drug Landscape Analysis by Major Types
-
11.2 Southwest China Candesartan Cilexetil Drug Landscape Analysis by Major End-Users
12 Northwest China Candesartan Cilexetil Drug Landscape Analysis
-
12.1 Northwest China Candesartan Cilexetil Drug Landscape Analysis by Major Types
-
12.2 Northwest China Candesartan Cilexetil Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 LUPIN
-
13.1.1 LUPIN Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 ANI Pharmaceuticals
-
13.2.1 ANI Pharmaceuticals Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Zydus Pharmaceuticals
-
13.3.1 Zydus Pharmaceuticals Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Mylan
-
13.4.1 Mylan Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 MACLEODS
-
13.5.1 MACLEODS Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Teva
-
13.6.1 Teva Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Sun Pharmaceutical
-
13.7.1 Sun Pharmaceutical Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Chongqing Shenghuaxi Pharma
-
13.8.1 Chongqing Shenghuaxi Pharma Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 AstraZeneca
-
13.9.1 AstraZeneca Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Alembic Pharmaceuticals
-
13.10.1 Alembic Pharmaceuticals Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Candesartan Cilexetil Drug Market Size and Growth Rate of 4 mg Tablets from 2016 to 2027
-
Figure China Candesartan Cilexetil Drug Market Size and Growth Rate of 8 mg Tablets from 2016 to 2027
-
Figure China Candesartan Cilexetil Drug Market Size and Growth Rate of 16 mg Tablets from 2016 to 2027
-
Figure China Candesartan Cilexetil Drug Market Size and Growth Rate of 32 mg Tablets from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Candesartan Cilexetil Drug Market Size and Growth Rate of Essential hypertension in adults from 2016 to 2027
-
Figure China Candesartan Cilexetil Drug Market Size and Growth Rate of Hypertension in children and adolescents aged 6 to < 18 years from 2016 to 2027
-
Figure China Candesartan Cilexetil Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Candesartan Cilexetil Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Candesartan Cilexetil Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Candesartan Cilexetil Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Candesartan Cilexetil Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Candesartan Cilexetil Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 4 mg Tablets
-
Figure Market Size and Growth Rate of 8 mg Tablets
-
Figure Market Size and Growth Rate of 16 mg Tablets
-
Figure Market Size and Growth Rate of 32 mg Tablets
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Candesartan Cilexetil Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Candesartan Cilexetil Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Essential hypertension in adults
-
Figure Market Size and Growth Rate of Hypertension in children and adolescents aged 6 to < 18 years
-
Figure Market Size and Growth Rate of Others
-
Table China Candesartan Cilexetil Drug Production by Regions
-
Table China Candesartan Cilexetil Drug Production Share by Regions
-
Figure China Candesartan Cilexetil Drug Production Share by Regions in 2016
-
Figure China Candesartan Cilexetil Drug Production Share by Regions in 2021
-
Figure China Candesartan Cilexetil Drug Production Share by Regions in 2027
-
Table China Candesartan Cilexetil Drug Consumption by Regions
-
Table China Candesartan Cilexetil Drug Consumption Share by Regions
-
Figure China Candesartan Cilexetil Drug Consumption Share by Regions in 2016
-
Figure China Candesartan Cilexetil Drug Consumption Share by Regions in 2021
-
Figure China Candesartan Cilexetil Drug Consumption Share by Regions in 2027
-
Table North China Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027
-
Table North China Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Candesartan Cilexetil Drug Consumption Share by Types in 2016
-
Figure North China Candesartan Cilexetil Drug Consumption Share by Types in 2021
-
Figure North China Candesartan Cilexetil Drug Consumption Share by Types in 2027
-
Table North China Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027
-
Table North China Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Candesartan Cilexetil Drug Consumption Share by End-Users in 2016
-
Figure North China Candesartan Cilexetil Drug Consumption Share by End-Users in 2021
-
Figure North China Candesartan Cilexetil Drug Consumption Share by End-Users in 2027
-
Table Central China Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027
-
Table Central China Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Candesartan Cilexetil Drug Consumption Share by Types in 2016
-
Figure Central China Candesartan Cilexetil Drug Consumption Share by Types in 2021
-
Figure Central China Candesartan Cilexetil Drug Consumption Share by Types in 2027
-
Table Central China Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Candesartan Cilexetil Drug Consumption Share by End-Users in 2016
-
Figure Central China Candesartan Cilexetil Drug Consumption Share by End-Users in 2021
-
Figure Central China Candesartan Cilexetil Drug Consumption Share by End-Users in 2027
-
Table South China Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027
-
Table South China Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Candesartan Cilexetil Drug Consumption Share by Types in 2016
-
Figure South China Candesartan Cilexetil Drug Consumption Share by Types in 2021
-
Figure South China Candesartan Cilexetil Drug Consumption Share by Types in 2027
-
Table South China Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027
-
Table South China Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Candesartan Cilexetil Drug Consumption Share by End-Users in 2016
-
Figure South China Candesartan Cilexetil Drug Consumption Share by End-Users in 2021
-
Figure South China Candesartan Cilexetil Drug Consumption Share by End-Users in 2027
-
Table East China Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027
-
Table East China Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Candesartan Cilexetil Drug Consumption Share by Types in 2016
-
Figure East China Candesartan Cilexetil Drug Consumption Share by Types in 2021
-
Figure East China Candesartan Cilexetil Drug Consumption Share by Types in 2027
-
Table East China Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027
-
Table East China Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Candesartan Cilexetil Drug Consumption Share by End-Users in 2016
-
Figure East China Candesartan Cilexetil Drug Consumption Share by End-Users in 2021
-
Figure East China Candesartan Cilexetil Drug Consumption Share by End-Users in 2027
-
Table Northeast China Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Candesartan Cilexetil Drug Consumption Share by Types in 2016
-
Figure Northeast China Candesartan Cilexetil Drug Consumption Share by Types in 2021
-
Figure Northeast China Candesartan Cilexetil Drug Consumption Share by Types in 2027
-
Table Northeast China Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Candesartan Cilexetil Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Candesartan Cilexetil Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Candesartan Cilexetil Drug Consumption Share by End-Users in 2027
-
Table Southwest China Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Candesartan Cilexetil Drug Consumption Share by Types in 2016
-
Figure Southwest China Candesartan Cilexetil Drug Consumption Share by Types in 2021
-
Figure Southwest China Candesartan Cilexetil Drug Consumption Share by Types in 2027
-
Table Southwest China Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Candesartan Cilexetil Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Candesartan Cilexetil Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Candesartan Cilexetil Drug Consumption Share by End-Users in 2027
-
Table Northwest China Candesartan Cilexetil Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Candesartan Cilexetil Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Candesartan Cilexetil Drug Consumption Share by Types in 2016
-
Figure Northwest China Candesartan Cilexetil Drug Consumption Share by Types in 2021
-
Figure Northwest China Candesartan Cilexetil Drug Consumption Share by Types in 2027
-
Table Northwest China Candesartan Cilexetil Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Candesartan Cilexetil Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Candesartan Cilexetil Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Candesartan Cilexetil Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Candesartan Cilexetil Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of LUPIN
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LUPIN
-
Figure Sales and Growth Rate Analysis of LUPIN
-
Figure Revenue and Market Share Analysis of LUPIN
-
Table Product and Service Introduction of LUPIN
-
Table Company Profile and Development Status of ANI Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ANI Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of ANI Pharmaceuticals
-
Figure Revenue and Market Share Analysis of ANI Pharmaceuticals
-
Table Product and Service Introduction of ANI Pharmaceuticals
-
Table Company Profile and Development Status of Zydus Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zydus Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Zydus Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Zydus Pharmaceuticals
-
Table Product and Service Introduction of Zydus Pharmaceuticals
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of MACLEODS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MACLEODS
-
Figure Sales and Growth Rate Analysis of MACLEODS
-
Figure Revenue and Market Share Analysis of MACLEODS
-
Table Product and Service Introduction of MACLEODS
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Sun Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical
-
Figure Revenue and Market Share Analysis of Sun Pharmaceutical
-
Table Product and Service Introduction of Sun Pharmaceutical
-
Table Company Profile and Development Status of Chongqing Shenghuaxi Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chongqing Shenghuaxi Pharma
-
Figure Sales and Growth Rate Analysis of Chongqing Shenghuaxi Pharma
-
Figure Revenue and Market Share Analysis of Chongqing Shenghuaxi Pharma
-
Table Product and Service Introduction of Chongqing Shenghuaxi Pharma
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Alembic Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alembic Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alembic Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alembic Pharmaceuticals
-
Table Product and Service Introduction of Alembic Pharmaceuticals
-
